EmblemHealth updated the Medical Necessity Guidelines: Experimental, Investigational or Unproven Services as shown in the revision history.
EmblemHealth updated the Varicose Vein Treatment medical guidelines to add Medicaid coverage of endovenous mechanochemical ablation and subfascial endoscopic perforator vein surgery.
EmblemHealth updated the Gene Expression Profiling medical guidelines to add:
- Commercial and Medicare coverage of the Abbott Alinity™ m STI Assay, Guardant Shield, and IsoPSA®tests.
- NavDx Medicare Coverage.
- ·Immunoscore® as investigational for all members.
EmblemHealth updated the Clinical Trials (Medicare) medical guidelines to add language clarifying that Category B devices that are integral to CMS-approved Category B Investigational Device Exemption (IDE) trials are covered.
EmblemHealth updated the Radiofrequency Ablation of Tumors medical guidelines to add nonmetastatic desmoid tumors to the investigational list.
ConnectiCare’s Medical Policy Updates
ConnectiCare updated the Experimental Investigational or Unproved Services Policy as shown in the revision history.
ConnectiCare updated the Clinical Trials (Medicare) medical guidelines to add language clarifying that Category B devices that are integral to CMS-approved Category B Investigational Device Exemption (IDE) trials are covered.
ConnectiCare updated the Radiofrequency Ablation of Tumors medical guidelines to add nonmetastatic desmoid tumors to the investigational list.
JP69647
